Vericel Corp. (VCEL)
37.76
+1.47
(+4.05%)
USD |
NASDAQ |
Jan 21, 16:00
37.76
0.00 (0.00%)
After-Hours: 17:41
Vericel Market Cap: 1.910B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics, Inc. | 4.128B |
| Vanda Pharmaceuticals, Inc. | 468.34M |
| Marker Therapeutics, Inc. | 36.35M |
| Veracyte, Inc. | 3.424B |
| Aldeyra Therapeutics, Inc. | 299.31M |
Market Cap Related Metrics
| PE Ratio | 156.81 |
| PS Ratio | 7.458 |
| PEG Ratio | 0.5485 |
| Price to Book Value | 5.933 |
| Price to Free Cash Flow | 94.69 |
| Price | 37.76 |
| Earnings Yield | 0.64% |
| PEGY Ratio | 0.5485 |
| Operating PE Ratio | 271.45 |
| Normalized PE Ratio | 156.75 |